From: "Pharma Sources" <cphichina@info.cphi-chinaedm.com>
Reply: "PharmaSources" <PharmaSources@imsinoexpo.com>
Date: Fri, 10 Sep 2021 16:25:47 +0800
Subject: PharmaSources E-Newsletter September 2021 Issue 1
What’s new in the Chinese pharma market: latest news, products and
events
View this e-mail
<Suspicious hyperlink>
<Suspicious hyperlink> online
E-NEWSLETTER
September 2021
[register for free ]
<Suspicious hyperlink>
Home
<Suspicious hyperlink>
Products
<Suspicious hyperlink>
Suppliers
<Suspicious hyperlink>
News
<Suspicious hyperlink>
EDITOR'S PICK
<Suspicious hyperlink> HIGH-VALUE MOLECULES GOING OFF-PATENT – FROM AN EMERGING MARKETS
PERSPECTIVE
Regulatory norms, application of intellectual property rights, disease
pattern, and market size vary considerably between developing
countries.
Read More
<Suspicious hyperlink>
MORE INDUSTRY INSIGHTS
* Akeso, Inc. Has Made Positive Progress on Bispecific Antibody with
Pipelines Enriched
<Suspicious hyperlink>
* A Brief Discussion on Roxadustat in the Midst of the Controversy
<Suspicious hyperlink>
* Application Status and Market Prospect of Oral Membrane
<Suspicious hyperlink>
HOT PRODUCTS
<Suspicious hyperlink>10%-30% Beta-carotene
Beta Carotene powder
Sage Extract Salvia
Officinalis Powder
Rebaudioside A 97% /98% Rebaudioside A Stevia Extract
<Suspicious hyperlink>Multi-functional intelligent automatic cartoning machine
<Suspicious hyperlink>BT5D
high temperature dry bath
BFS leak tester
in pharmaceutical
Source More Products
<Suspicious hyperlink>
WE WANT YOU!
Become a PHARMA PRODUCT WRITER
<Suspicious hyperlink> for
PharmaSources.com to Reach the Right Audience
Customer Service
(+86) 400 610 1188
PharmaSources@imsinoexpo.com
unsubscribe
<Suspicious hyperlink>